Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Leap Therapeutics, Inc. (NASDAQ: LPTX).

Full DD Report for LPTX

You must become a subscriber to view this report.


Recent News from (NASDAQ: LPTX)

Leap Therapeutics Reports First Quarter 2018 Financial Results
CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended March 31, 2018. “We had a strong first quarter, as w...
Source: GlobeNewswire
Date: May, 11 2018 07:00
Midday Gainers / Losers (04/16/2018)
Gainers: OSN +26% . ERI +17% . SHOS +13% . APLS +13% . HEAR +13% . FTD +12% . FSCT +12% . OASM +11% . PMTS +11% . BXC +11% . More news on: Ossen Innovation Co., Ltd., Eldorado Resorts, Inc., Sears Hometown and Outlet Stores, Inc., Stocks on the move, , ...
Source: SeekingAlpha
Date: April, 16 2018 12:40
Investors underwhelmed with Leap's early-stage DKN-01 data; shares down 23%
Thinly traded micro cap Leap Therapeutics ( LPTX -23.1% ) slumps on almost triple normal volume, albeit on turnover of only 321K shares, in apparent response to its announcement of preliminary results from the dose-escalation phase of its study assessing DKN-01 with Merck's KEYTRUDA (pem...
Source: SeekingAlpha
Date: April, 16 2018 11:36
Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting
CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX) today presented nonclinical and clinical data on DKN-01, Leap’s anti-DKK1 monoclonal antibody, at the American Association for Cancer Research (AACR) 2018 Annual Meeting. The presentation highl...
Source: GlobeNewswire
Date: April, 16 2018 09:00
Leap Therapeutics (LPTX) Presents At Needham and Company 17th Annual Healthcare Conference - Slideshow
The following slide deck was published by Leap Therapeutics in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 29 2018 14:06
New Research Coverage Highlights Holly Energy Partners, Liberty Property Trust, Fair Isaac, 58, Cousins Properties, and Leap Therapeutics - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Holly Energy Partners, L.P. (NYSE:HEP), Liberty Property Trust (NYSE:LPT...
Source: GlobeNewswire
Date: March, 28 2018 08:00
Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., March 27, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of a public offering of 2,146,667 shares of its common stock, which includes the s...
Source: GlobeNewswire
Date: March, 27 2018 16:05
Leap Therapeutics prices public offering of common stock
Leap Therapeutics (NASDAQ: LPTX ) prices  its public offering of 1.9M shares of common stock at $7.50 per share yielding gross proceeds of ~$14M. Underwriters over-allotment is an additional 280K shares. More news on: Leap Therapeutics, Healthcare stocks news, Read more...
Source: SeekingAlpha
Date: March, 23 2018 10:01
Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock
CAMBRIDGE, Mass., March 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering of 1,866,667 shares of its common stock at a pu...
Source: GlobeNewswire
Date: March, 23 2018 09:00
After Hours Gainers / Losers (3/22/2018)
Top gainers: SGH +11.2% . HOME +8.1% . NKE +7.1% . GSUM +3.9% . CTAS +3.5% . More news on: SMART Global Holdings, At Home Group, Nike Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: March, 22 2018 17:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-178.087.788.487.6829119,875

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-245,6878,18069.5232Short
2018-05-238,86623,35437.9635Short
2018-05-2215,19024,35762.3640Short
2018-05-2119,55239,31049.7380Short
2018-05-1814,85853,71427.6613Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on LPTX.


About Leap Therapeutics, Inc. (NASDAQ: LPTX)

Logo for Leap Therapeutics, Inc. (NASDAQ: LPTX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $126,568,557 - 05/11/2018
  • Issue and Outstanding: 17,057,757 - 12/31/2015

 


Recent Filings from (NASDAQ: LPTX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 22 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: March, 22 2018

 

 


Daily Technical Chart for (NASDAQ: LPTX)

Daily Technical Chart for (NASDAQ: LPTX)


Stay tuned for daily updates and more on (NASDAQ: LPTX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: LPTX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in LPTX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of LPTX and does not buy, sell, or trade any shares of LPTX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/